Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
13.82
-0.78 (-5.34%)
At close: Dec 18, 2025, 4:00 PM EST
13.50
-0.32 (-2.32%)
After-hours: Dec 18, 2025, 7:44 PM EST
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $11.59 million as of December 18, 2025. Its market cap has increased by 282.68% in one year.
Market Cap
11.59M
Enterprise Value
8.95M
1-Year Change
282.68%
Ranking
Category
Stock Price
$13.82
Market Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $11.59M, a decrease of -88.07%. That is a compound annual growth rate of -40.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 12.25M | 129.92% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | 97.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |